Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Molecular Therapy. Nucleic Acids|January 31, 2024
Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in vitro and in vivoElena M Smekalova, Maria G Martinez, Emmanuel Combe, et al.
STAR Protocols|October 5, 2024
Protocol for isolating CD163+ Kupffer cells from human liver resectionsArmando Andres Roca Suarez, Marie-Laure Plissonnier, Maud Michelet, et al.
Journal of Hepatology|December 5, 2020
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patientsMireia García-López, Sabela Lens, Laura J Pallett, et al.
Journal of Hepatology|May 23, 2024
Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytesFleur Chapus, Guillaume Giraud, Pélagie Huchon, et al.
Journal of Hepatology|June 21, 2019
Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesisMarc Bonnin, Nadim Fares, Barbara Testoni, et al.
Frontiers in Cellular and Infection Microbiology|September 20, 2023
Interspecies comparison of the early transcriptomic changes associated with hepatitis B virus exposure in human and macaque immune cell populationsArmando Andres Roca Suarez, Séverine Planel, Xavier Grand, et al.
Human Molecular Genetics|June 1, 2021
Variants in USP48 encoding ubiquitin hydrolase are associated with autosomal dominant non-syndromic hereditary hearing lossSissy Bassani, Edward van Beelen, Mireille Rossel, et al.
Plos Genetics|April 19, 2014
A general approach for haplotype phasing across the full spectrum of relatednessJared O'Connell, Deepti Gurdasani, Olivier Delaneau, et al.
Journal of Hepatology|December 11, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis deltaElisabetta Degasperi, Caroline Scholtes, Barbara Testoni, et al.
Pageof 14